Aaron N. Chang

Grand Rapids Community College — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index4.2kcitations89works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(26), RNA modifications and cancer(26), RNA Research and Splicing(11), Cancer-related molecular mechanisms research(9), Muscle Physiology and Disorders(7)

Publications89 total

3′-end ligation sequencing is a sensitive method to detect DNA nicks at potential sites of off-target activity induced by prime editors
Genome Research·2025Open Access
Weather, Air Pollution, and Seasonality: Predictors of Pathogen-Associated Conjunctivitis Outbreaks in Kathmandu Valley, Nepal
American Journal of Tropical Medicine and Hygiene·2025· 2 citedOpen Access
Modulating the activity of the <scp>APC</scp> /C regulator <scp>SISAMBA</scp> improves the sugar and antioxidant content of tomato fruits
Plant Biotechnology Journal·2025· 2 citedOpen Access
Practice Patterns, Diagnostic Utility, and Safety of Anterior Chamber Paracentesis
American Journal of Ophthalmology·2025
Real-World Use of Dalbavancin in a United States Tertiary Referral Center
Cureus·2025Open Access
Modulating activity of the APC/C regulator SISAMBA improves the sugar and antioxidant content of tomato fruits
2024Open Access
Visual Prompting in Multimodal Large Language Models: A Survey
arXiv (Cornell University)·2024· 4 citedOpen Access
Abstract IA012: REGN10597: A PD-1-targeted, receptor-masked wild type IL-2 with improved therapeutic window for cancer immunotherapy
Molecular Cancer Therapeutics·2023
Comprehensive Profile of Pathogens and Antimicrobial Resistance in Conjunctivitis Cases from Niger
American Journal of Tropical Medicine and Hygiene·2023· 2 citedOpen Access
Abstract 4434: A PD-1-targeted, receptor-masked IL-2 immunocytokine with maintained potential to engage endogenous IL-2Ra drives selective stimulation of PD-1+ T cells and robust anti-tumor efficacy
Cancer Research·2023· 2 cited
Supplementary Table B from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table E from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table A from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table E from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Data from Identification of &lt;i&gt;SULF2&lt;/i&gt; as a Novel Transcriptional Target of p53 by Use of Integrated Genomic Analyses
2023Open Access
Supplementary Figure and Table Legends from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table B from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table D from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Figure 1 from Identification of &lt;i&gt;SULF2&lt;/i&gt; as a Novel Transcriptional Target of p53 by Use of Integrated Genomic Analyses
2023Open Access
Supplementary Table C from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Peter S. Linsley(7), Michele A. Cleary(7), Owen B. Wallace(6), Janell M. Schelter(5), Michael Carleton(5), Cornelis Murre(5), Andrei Goga(5), Diego Cadavid(5), B. Nelson Chau(4), Stuart H. Orkin(4), Kathleen M. Fisch(4), Lucienne Ronco(4), Angela Cacace(4), Sara A. Georges(3), Matthew C. Biery(3), Soo‐Yeon Kim(3), Jane Guo(3), Aimee L. Jackson(3), Vivek Chandra(3), Ryan Walsh(3)